Literature DB >> 8893785

Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia.

D K Lvov1, E I Samokhvalov, F Tsuda, N A Selivanov, H Okamoto, V M Stakhanova, I V Stakhgildyan, N V Doroshenko, T L Yashina, S N Kuzin, I A Suetina, P G Deryabin, L A Ruzaeva, V N Bezgodov, L A Firsova, S N Sorinson, S Mishiro.   

Abstract

We tested hepatitis C virus (HCV) antibody in 4216 sera collected from healthy people living in European part of Russia (including Northern, North-Western, Central, Central-Blacksoil, Volga-Vyatka, Volga, and North-Caucasian regions), non-European part of Russia (the Urals, East-Siberia, and the Far-East regions) and Mongolia. Prevalence of HCV antibody varied significantly by regions, ranging from 0.7% in Central region of European part of Russia to 10.7% in Mongolia. Genotyping of HCV (into 1a, 1b, 2a, 2b, and 3a) was performed on 469 sera from blood donors and patients (in Russia, Moldova, Turkmenistan, and Mongolia) who were positive for both HCV antibody and RNA. Genotype 1b was the most dominant genotype irrespective of regions (68.9%), with the highest rate in Moldova (96%). HCV unclassifiable into genotypes 1a-to-3a was found in 28 (6.0%) samples: particularly 4 of 10 samples from Lipetzk were untypable. Overall, HCV genotypes in European part of Russia were more similar to those in European countries, while those in Eastern part of Russia more similar to China or Japan. Genotype distribution was not associated with the clinical expression of HCV disease: acute hepatitis, chronic hepatitis or liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893785     DOI: 10.1007/bf01718286

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Analysis of the putative E1 envelope and NS4a epitope regions of HCV type 3.

Authors:  L Stuyver; W Van Arnhem; A Wyseur; R DeLeys; G Maertens
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

3.  Genotyping of hepatitis C virus in South Africa.

Authors:  H E Smuts; J Kannemeyer
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

4.  Heterogeneity of hepatitis C virus genotypes in France.

Authors:  D Qu; O Hantz; M Gouy; L Vitvitski; J S Li; F Berby; S P Tong; C Trépo
Journal:  J Gen Virol       Date:  1994-05       Impact factor: 3.891

5.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

Authors:  H Okamoto; H Tokita; M Sakamoto; M Horikita; M Kojima; H Iizuka; S Mishiro
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

6.  The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease.

Authors:  H Okamoto; M Kojima; M Sakamoto; H Iizuka; S Hadiwandowo; S Suwignyo; Y Miyakawa; M Mayumi
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

7.  Prevalence of hepatitis C virus sequence variants in South-East Asia.

Authors:  W K Greene; M K Cheong; V Ng; K W Yap
Journal:  J Gen Virol       Date:  1995-01       Impact factor: 3.891

Review 8.  Genetic heterogeneity of hepatitis C virus.

Authors:  H Okamoto; S Mishiro
Journal:  Intervirology       Date:  1994       Impact factor: 1.763

9.  Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

Authors:  S W Chan; F McOmish; E C Holmes; B Dow; J F Peutherer; E Follett; P L Yap; P Simmonds
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

10.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

View more
  11 in total

1.  Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: a population-based survey of the adult population of T'bilisi, Republic of Georgia.

Authors:  Ketevan Stvilia; Tengiz Tsertsvadze; Lali Sharvadze; Malvina Aladashvili; Carlos del Rio; Mark H Kuniholm; Kenrad E Nelson
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

2.  Full-genome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2 (arbitrarily 2k).

Authors:  E I Samokhvalov; M Hijikata; R I Gylka; D K Lvov; S Mishiro
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

3.  Breast cancer incidence in Mongolia.

Authors:  Rebecca Troisi; Dalkhjav Altantsetseg; Ganmaa Davaasambuu; Janet Rich-Edwards; Dambadarjaa Davaalkham; Steinar Tretli; Robert N Hoover; A Lindsay Frazier
Journal:  Cancer Causes Control       Date:  2012-04-29       Impact factor: 2.506

4.  Cohort study of familial viral hepatitis and risks of paediatric cancers.

Authors:  Julia E Heck; Chia-Kai Wu; Xiwen Huang; Kara W Chew; Myron Tong; Noah Federman; Beate Ritz; Onyebuchi A Arah; Chung-Yi Li; Fei Yu; Jorn Olsen; Johnni Hansen; Pei-Chen Lee
Journal:  Int J Epidemiol       Date:  2022-05-09       Impact factor: 9.685

5.  Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Daghestan.

Authors:  D T Abdourakhmanov; A S Hasaev; F J Castro; J Guardia
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

Review 6.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

7.  High prevalence of antibodies to hepatitis A and E viruses and viremia of hepatitis B, C, and D viruses among apparently healthy populations in Mongolia.

Authors:  Masaharu Takahashi; Tsutomu Nishizawa; Yuhko Gotanda; Fumio Tsuda; Fumio Komatsu; Terue Kawabata; Kyoko Hasegawa; Murdorjyn Altankhuu; Ulziiburen Chimedregzen; Luvsanbasaryn Narantuya; Hiromi Hoshino; Kunihiko Hino; Yasuo Kagawa; Hiroaki Okamoto
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

Review 8.  Acute hepatitis C: management in the rapidly evolving world of HCV.

Authors:  Suraj A Sharma; Jordan J Feld
Journal:  Curr Gastroenterol Rep       Date:  2014-02

9.  Anti-HCV prevalence in the general population of Lithuania.

Authors:  Valentina Liakina; Jonas Valantinas
Journal:  Med Sci Monit       Date:  2012-03

Review 10.  Hepatitis C in the Russian Federation: challenges and future directions.

Authors:  Sergey Mukomolov; Galina Trifonova; Irina Levakova; Daria Bolsun; Eugenia Krivanogova
Journal:  Hepat Med       Date:  2016-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.